Researchers from Italy have found encouraging results from their review of the current evidence on the psychological, safety, and exercise-related outcomes of the t:slim X2 insulin pump with Control-IQ technology from Tandem Diabetes Care in children, adolescents, and young adults with Type 1 diabetes.
The review found that Control-IQ technology is not only safe but also effective in improving key quality-of-life measures:
- Significant reduction in fear of hypoglycemia for young people and their parents
- Decreased diabetes-related distress
- Improved sleep quality for both patients and caregivers
- Lower risk of exercise-related hypoglycemia
The review concluded that “this second-generation automated insulin delivery system reduces the burden of diabetes. It properly addresses most psychological issues in children, adolescents, and young adults with Type 1 diabetes.”
To find out more, CLICK HERE.
